Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-25
SponsorKafrelsheikh University
About this trial
This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).
Eligibility criteria
Qualifiers
Age ranges from 20-25 years old.
Body mass index (BMI) doesn't exceed 30 kg/m2.
Patients referred from a Gynecologist with a diagnosis of Primary Dysmenorrhea (PD).
Patients have regular menstrual cycles.
Disqualifiers
Patients diagnosed with gynecological pathology.
Patients taking oral contraceptives or had an intrauterine device implanted.
Patients had bad obstetric situations or diseases that could interfere with participation.
Patients have certain disorders including uncorrected coagulopathies, severe comorbid disorder, cancer in the last 5 years or at present, presence of erosions on the inner aspect of the ankle, severe mental disorders, or neuropathies affecting the lower limb.
Trial design
Treatments tested in this trial
- Transcutaneous tibial nerve stimulation (TTNS)
- Traditional treatment (Nonsteroidal anti-inflammatory drugs)
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov